Spots Global Cancer Trial Database for progressive
Every month we try and update this database with for progressive cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Nivolumab for Recurrent or Progressive IDH Mutant Gliomas | NCT03557359 | Gliomas | Nivolumab | 18 Years - | Columbia University | |
| A Trial to Find Out How Safe REGN5668 is and How Well it Works When Given With Either Cemiplimab or REGN4018 | NCT04590326 | Ovarian Cancer Fallopian Tube ... Primary Periton... Endometrial Can... | REGN5668 Cemiplimab REGN4018 Sarilumab | 18 Years - | Regeneron Pharmaceuticals | |
| Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP | NCT02983097 | Diffuse Large B... Follicular Lymp... Mantle Cell Lym... Burkitt Lymphom... Aggressive Marg... | Rituximab Cisplatin Carboplatin Dexamethasone Cytarabine Lenalidomide PegFilgrastim peripheral stem... | 18 Years - 70 Years | Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | |
| Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma | NCT00545545 | Recurrent Color... Progressive Col... | Safety and effi... Safety and effi... | 18 Years - 75 Years | HiberCell, Inc. | |
| Study of Proteus Syndrome and Related Congenital Disorders | NCT00001403 | Proteus Syndrom... PIK3CA Related ... | 1 Month - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer | NCT01288911 | Prostatic Neopl... | enzalutamide bicalutamide | 18 Years - | Astellas Pharma Inc | |
| Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System Lymphoma | NCT00712062 | Primary Central... | Pemetrexed | 18 Years - | University of Florida | |
| Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer | NCT01774578 | Non-small Cell ... Progression of ... Non-small Cell ... | Docetaxel HyperAcute®-Lun... Gemcitabine Pemetrexed | 18 Years - | Lumos Pharma | |
| Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin) | NCT01524783 | Advanced NET of... Advanced NET of... Neuroendocrine ... | Everolimus Placebo Best suportive ... | 18 Years - | Novartis | |
| A Phase I, Open-label, Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Endothelin B Agonist, SPI-1620, in Patients With Recurrent or Progressive Carcinoma | NCT00613691 | Carcinoma | SPI-1620 | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| A Study of Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid Tumors | NCT01731925 | Carcinoid Tumor... | Lanreotide Placebo (for su... Sunitinib | 18 Years - | GERCOR - Multidisciplinary Oncology Cooperative Group | |
| Post-Marketing Surveillance of Lenvima in Korean Patients | NCT02764554 | Differentiated ... | - | Eisai Inc. | ||
| Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer | NCT01068249 | Endometrial Can... | Letrozole RAD001 (Everoli... | 18 Years - | M.D. Anderson Cancer Center | |
| Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1) | NCT06193174 | Recurrent Malig... Glioblastoma Mu... Gliosarcoma of ... Anaplastic Astr... | C134 Re-Adminis... | 18 Years - | University of Alabama at Birmingham | |
| Study of Pembrolizumab and M032 (NSC 733972) | NCT05084430 | Glioblastoma Mu... Anaplastic Astr... Gliosarcoma | M032 Pembrolizumab | 18 Years - | University of Alabama at Birmingham | |
| Vinorelbine for Children With Progressive or Recurrent Low-grade Gliomas | NCT01497860 | Low-grade Gliom... | Vinorelbine | - 18 Years | Children's National Research Institute | |
| Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases. | NCT03869762 | Castration-resi... Metastatic Canc... Bone Metastases | Xgeva Xtandi | 18 Years - | Cancer Trials Ireland | |
| Perifosine With Temsirolimus for Recurrent Pediatric Solid Tumors | NCT01049841 | Pediatric Solid... | perifosine + te... | - 21 Years | Memorial Sloan Kettering Cancer Center | |
| A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer | NCT01288911 | Prostatic Neopl... | enzalutamide bicalutamide | 18 Years - | Astellas Pharma Inc | |
| Study of Oral Ridaforolimus (AP23573, MK-8669) to Treat Patients With Refractory or Advanced Malignancies (MK-8669-016 AM4)(COMPLETED) | NCT00112372 | Cancer | Ridaforolimus | 18 Years - | Merck Sharp & Dohme LLC | |
| Nivolumab for Recurrent or Progressive IDH Mutant Gliomas | NCT03557359 | Gliomas | Nivolumab | 18 Years - | Columbia University | |
| Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial | NCT01010243 | Multiple Myelom... | Lenalidomide, P... | 18 Years - | University of Regensburg | |
| Study of Proteus Syndrome and Related Congenital Disorders | NCT00001403 | Proteus Syndrom... PIK3CA Related ... | 1 Month - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer | NCT02460367 | Non-small Cell ... Progression of ... Non-small Cell ... | Docetaxel Tergenpumatucel... Indoximod | 18 Years - | Lumos Pharma | |
| Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer | NCT02460367 | Non-small Cell ... Progression of ... Non-small Cell ... | Docetaxel Tergenpumatucel... Indoximod | 18 Years - | Lumos Pharma | |
| Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial | NCT01010243 | Multiple Myelom... | Lenalidomide, P... | 18 Years - | University of Regensburg | |
| Inhalation SLIT Cisplatin (Liposomal) for the Treatment of Osteosarcoma Metastatic to the Lung | NCT00102531 | Osteosarcoma Me... | Cisplatin lipos... | 13 Years - 50 Years | Insmed Incorporated | |
| Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer | NCT02460367 | Non-small Cell ... Progression of ... Non-small Cell ... | Docetaxel Tergenpumatucel... Indoximod | 18 Years - | Lumos Pharma | |
| Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer | NCT01068249 | Endometrial Can... | Letrozole RAD001 (Everoli... | 18 Years - | M.D. Anderson Cancer Center | |
| Everolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas | NCT01158651 | Glioma | RAD001 (Everoli... | 1 Year - 21 Years | University of Alabama at Birmingham |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
